Your browser doesn't support javascript.
loading
Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn, Ji-Hye; Lee, Kyung-Tae; Choi, Youn Seok; Choi, Jung-Hye.
Afiliação
  • Ahn JH; Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul 02447, South Korea; Division of Molecular Biology, College of Pharmacy, Kyung Hee University, Seoul 02447, South Korea.
  • Lee KT; Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul 02447, South Korea.
  • Choi YS; Department of Obstetrics and Gynecology, School of Medicine, Catholic University of Daegu, Daegu 42472, South Korea.
  • Choi JH; Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul 02447, South Korea; Division of Molecular Biology, College of Pharmacy, Kyung Hee University, Seoul 02447, South Korea. Electronic address: jchoi@khu.ac.kr.
Article em En | MEDLINE | ID: mdl-29292033

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Regulação para Baixo / Iloprosta / Epoprostenol / Metaloproteinase 2 da Matriz / Receptores de Epoprostenol Limite: Female / Humans Idioma: En Revista: Prostaglandins Other Lipid Mediat Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Regulação para Baixo / Iloprosta / Epoprostenol / Metaloproteinase 2 da Matriz / Receptores de Epoprostenol Limite: Female / Humans Idioma: En Revista: Prostaglandins Other Lipid Mediat Ano de publicação: 2018 Tipo de documento: Article